Valacer D J, O'Reilly M E, Ilowite N T, Bonagura V R
Division of Pediatric Allergy and Immunology, Schneider Children's Hospital, Long Island Jewish Medical Center, Hyde Park, NY 11042.
J Allergy Clin Immunol. 1991 Sep;88(3 Pt 1):349-55. doi: 10.1016/0091-6749(91)90096-7.
Anti-idiotypic (Id) antibodies (Abs) are generated in the humoral response to antigen (Ag). Some of these anti-Id Abs are capable of binding to the combining site or paratope of Abs that bind Ag. These Ab2 can competitively inhibit the binding of Ab1 to Ag may trigger an Ab1 response similar to the response induced by Ag. To determine if specific Ab2 that inhibit the binding of IgE Abs to ryegrass (RG)-pollen allergens are present in the sera of RG-allergic (RGA) individuals before the initiation of allergen-specific hyposensitization with RG-pollen extract, we studied sera from five RGA and four nonallergic (NA) subjects in an IgE anti-RG RAST-inhibition assay. Ab2-enriched serum fractions were prepared from these study subjects by exhaustive mixed grass-pollen affinity chromatography to remove IgE and IgG anti-RG Ab1 from whole serum aliquots containing Ab1. Unabsorbed, twice-concentrated sera were diluted to one-time concentrated sera with equal volumes of either Ab2-enriched sera without Ab1 or borate-buffered saline absorbed by mixed grass-pollen affinity chromatography. IgE anti-RG Ab1 was determined by a standard RG RAST assay. We have detected Ab2 in the sera of the RGA patients, which inhibit the binding of autologous and allogeneic IgE anti-RG to RG Ags in solid phase. Parallel RG RAST assays with sera from NA subjects demonstrated no significant inhibition. Ab2-enriched sera from some grass-allergic and some NA subjects inhibited IgE anti-RG binding found in some RGA patients' sera. We conclude that anti-Id Abs, Ab2, specific for IgE anti-RG, Ab1, are present in some RGA patients and NA individuals.
抗独特型(Id)抗体(Abs)是在对抗原(Ag)的体液免疫反应中产生的。其中一些抗Id抗体能够结合与抗原结合的抗体的结合位点或互补决定区。这些Ab2可以竞争性抑制Ab1与Ag的结合,也可能引发类似于抗原诱导反应的Ab1反应。为了确定在开始用黑麦草(RG)花粉提取物进行过敏原特异性减敏治疗之前,RG过敏(RGA)个体的血清中是否存在抑制IgE抗体与RG花粉过敏原结合的特异性Ab2,我们在IgE抗RG放射变应原吸附试验(RAST)中研究了5名RGA患者和4名非过敏(NA)受试者的血清。通过详尽的混合草花粉亲和层析从含有Ab1的全血清等分试样中去除IgE和IgG抗RG Ab1,从而从这些研究对象中制备富含Ab2的血清组分。将未吸收的、两倍浓缩的血清用等量的不含Ab1的富含Ab2的血清或经混合草花粉亲和层析吸收的硼酸盐缓冲盐水稀释至一倍浓缩的血清。通过标准的RG RAST试验测定IgE抗RG Ab1。我们在RGA患者的血清中检测到了Ab2,它能抑制固相中的自体和异体IgE抗RG与RG抗原的结合。对NA受试者血清进行的平行RG RAST试验未显示出明显的抑制作用。来自一些草过敏和一些NA受试者的富含Ab2的血清抑制了一些RGA患者血清中IgE抗RG的结合。我们得出结论,在一些RGA患者和NA个体中存在针对IgE抗RG(Ab1)的抗Id抗体Ab2。